NDC11 55513013221
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55513-0132-21 | 55513-0132 |
| 55513-132-21 | 55513-132 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kanjinti | TRASTUZUMAB-ANNS | Amgen, Inc | 9a94f5b2-b84e-4987-8ea1-c4346db5a5fa | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 55513-132-21 55513-132 55513013221 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.